Study indicates treatment using insulin may restore vision in glaucoma patients. San Francisco, CA - July 31, 2018 - Glaucoma Research Foundation, a national non-profit organization dedicated to finding a cure for glaucoma, today announced a team of neuroscience researchers,...
Read More »Aerie Pharmaceuticals has announced the launch of Rhopressa, a novel eye drop indicated for lowering elevated intraocular pressure in patients with glaucoma.
Read More »Glaucoma Research Foundation hosted our 2018 Annual Dinner at the historic San Francisco War Memorial and Performing Arts Center on April 24, 2018.
Read More »
GRF has announced the celebration of its 40th anniversary year, the board approval of its new strategic plan, and an expanded capital campaign designed to accelerate research towards a cure.
Read More »
The announcement during World Glaucoma Week emphasizes the need to find better treatments and a cure for this disease that affects more than 60 million people.
Read More »The 2018 Shaffer Prize was presented to Dr. Carla Siegfried during ceremonies at the Glaucoma 360 Annual Gala on February 8th at the Palace Hotel in San Francisco.
Read More »A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released in the Proceedings of the National Academy of Sciences (PNAS).
Read More »Researchers at Emory Eye Center report that a protein that affects corneal thickness might also be connected to glaucoma risk.
Read More »National Glaucoma Awareness Month is an important time to spread the word about this sight-stealing disease that affects more than 3 million people in the United States and 60 million worldwide.
Read More »Vision scientists at UC Berkeley and the University of Toronto have discovered that naturally occurring molecules known as lipid mediators have the potential to halt the progression of glaucoma, the world’s second-leading cause of blindness.
Read More »
